Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

974.07 -29.50 (-2.94%)

Streaming Delayed Price Updated: 12:45 PM EST, Mar 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

99 100 Next >

Prediction: This Healthcare Stock Could Soar by 40% in 2026 ↗

January 26, 2026

This pharmaceutical giant has recently caught fire, and the stock's run is likely just beginning.

Via The Motley Fool

My Top AI Healthcare Stock to Buy and Hold for 20 Years ↗

January 26, 2026

This drugmaker continues to strengthen its investment thesis.

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

Eli Lilly & Co (NYSE:LLY) Presents a Compelling Mix of Fundamental Growth and Technical Breakout Potential ↗

January 26, 2026

Via Chartmill

3 Mid-Cap Stocks with Open Questions

January 25, 2026

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with...

Via StockStory

Novo Nordisk In Green After Oral Wegovy Clocks Over 18K Prescriptions In A Week ↗

January 23, 2026

Via Stocktwits

ELI LILLY & CO (NYSE:LLY) Offers a Durable Dividend with Strong Growth and Financial Health ↗

January 23, 2026

Via Chartmill

3 Growth Stocks to Invest $1,000 in Right Now ↗

January 24, 2026

It comes as no surprise that all three of them are capitalizing on relatively new, but game-changing, developments.

Via The Motley Fool

Topics Artificial Intelligence

Should You Dump Eli Lilly's Shares After This Setback? ↗

January 24, 2026

The company got some bad news to start 2026.

Via The Motley Fool

Google, Nvidia, Lilly Lead 5 Stocks Near Buy Points ↗

January 24, 2026

These trillion-dollar stocks may be setting up for their next move.

Via Investor's Business Daily

The $5 Trillion Renaissance: How 2025 Redefined Global Deal-Making

January 23, 2026

The global financial landscape has undergone a seismic shift as 2025 closed with merger and acquisition (M&A) volumes surpassing a staggering $5 trillion. This "M&A Renaissance" marks a definitive end...

Via MarketMinute

Topics Artificial Intelligence Economy

Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead? ↗

January 23, 2026

Eli Lilly's valuation has been driven higher by investor excitement around GLP-1 drugs, leaving other drugmakers languishing.

Via The Motley Fool

Why a 15% Dividend Wasn’t Enough to Keep This $3.3 Million Position ↗

January 23, 2026

Trinity Capital provides venture debt and equipment financing to growth-stage tech companies seeking non-dilutive capital solutions.

Via The Motley Fool

Topics Regulatory Compliance

Outfront Media Surges 40% in One Year, Then Gets Cut Loose Despite 'Exceptional Performance' ↗

January 23, 2026

This out-of-home advertising REIT connects brands with urban audiences through a broad network of billboard and transit assets.

Via The Motley Fool

Topics Regulatory Compliance

Viking Therapeutics (VKTX) 2026 Deep Dive: Challenging the Obesity Duopoly

January 23, 2026

Date: January 23, 2026 Introduction In the high-stakes arena of metabolic medicine, few companies have generated as much speculative fervor and clinical awe as Viking Therapeutics (NASDAQ: VKTX). As of...

Via Finterra

Topics Intellectual Property

Oral Wegovy Is Off To An Astronomical Launch. Will It Save Novo Nordisk Stock? ↗

January 23, 2026

Novo Nordisk stock rose Friday on report its oral Wegovy clocked 18,000 prescriptions in its second week on the market.

Via Investor's Business Daily

Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 ↗

January 23, 2026

This biotech has candidates in late-stage clinical development.

Via The Motley Fool

2 Mega-Cap Stocks to Target This Week and 1 We Find Risky

January 22, 2026

Megacap stocks are behemoths that set the tone for their industries, and their massive scale typically leads to wide moats. However, the downside is that most have already exploited their existing...

Via StockStory

The Trillion-Dollar Heavyweight: Eli Lilly Surge Signals Unrivaled Dominance in the GLP-1 Era

January 22, 2026

Eli Lilly (NYSE: LLY) has once again demonstrated its resilience and market-leading strength, logging a significant 5.2% gain over the last five trading days as of January 22, 2026. This recent rally...

Via MarketMinute

Topics Economy

The Great Broadening: Why Early 2026 is Redefining the Market’s Winning Ticket

January 22, 2026

As the first month of 2026 draws to a close, the narrative that dominated Wall Street for the better part of three years—the undisputed reign of mega-cap technology—is rapidly fracturing. In its place,...

Via MarketMinute

Topics Economy

As Jensen Huang Preps to Visit China, How Should You Play Nvidia Stock?

January 22, 2026

Nvidia is a tech stock that has outpaced the broader markets by a significant margin over the past decade. Is NVDA still a good buy as Jensen Huang prepares to visit China?

Via Barchart.com

Topics Artificial Intelligence Government Supply Chain

The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market

January 22, 2026

The U.S. biotech sector has officially entered a new golden age. As of January 22, 2026, the industry is witnessing a "renaissance" that has effectively erased the memories of the grueling three-year...

Via MarketMinute

Topics Artificial Intelligence ETFs Initial Public Offering

Eli Lilly (LLY) Q2 2025 Earnings Call Transcript ↗

January 22, 2026

Eli Lilly (LLY) Q2 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Eli Lilly (LLY) Q3 2024 Earnings Call Transcript ↗

January 22, 2026

Eli Lilly (LLY) Q3 2024 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Eli Lilly (LLY) Q4 2024 Earnings Call Transcript ↗

January 22, 2026

Eli Lilly (LLY) Q4 2024 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Eli Lilly and Co's Options Frenzy: What You Need to Know ↗

January 22, 2026

Via Benzinga

ELI LILLY AND COMPANY INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Eli Lilly and Company’s Directors and Officers for Breach of Fiduciary Duties – LLY

January 22, 2026

From Scott+Scott Attorneys at Law LLP

Via Business Wire

Why Eli Lilly (LLY) Stock Is Up Today

January 21, 2026

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.5% in the afternoon session after the U.S. Food and Drug Administration (FDA) granted a Breakthrough Therapy designation for its...

Via StockStory

Topics Artificial Intelligence Supply Chain

Beyond the Silicon: NVIDIA and Eli Lilly Launch $1 Billion ‘Physical AI’ Lab to Rewrite the Rules of Medicine

January 21, 2026

In a move that signals the arrival of the "Bio-Computing" era, NVIDIA (NASDAQ: NVDA) and Eli Lilly (NYSE: LLY) have officially launched a landmark $1 billion AI co-innovation lab. Announced during the...

Via TokenRing AI

Topics Artificial Intelligence Economy Intellectual Property

J&J Forecasts $100 Billion Milestone for 2026 as Trump Drug Pricing Deals Reshape the Pharma Landscape

January 21, 2026

NEW BRUNSWICK, N.J. — In a landmark display of resilience and strategic pivoting, Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2025 revenues of $24.56 billion on Wednesday, January 21, 2026,...

Via MarketMinute

Topics Earnings Economy Government

Eli Lilly Stock Report: Momentum, Earnings And Analyst Targets ↗

January 21, 2026

Eli Lilly's stock is experiencing short-term volatility due to its proximity to a 52-week high and upcoming earnings, amid strong analyst support and mixed technical indicators.

Via Talk Markets

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.